For planned acquisitions or licensing, a careful analysis of CMCl factors is vital to ensure no problem areas are overlooked.
William J. Lambert
Advertisement
William J. Lambert, PhD, is principal, Module 3 Pharmaceutical Consulting, Incline Village, NV.
Articles by William J. Lambert
Advertisement
Latest Updated Articles
Due Diligence Assessment of CMC ActivitiesPublished: October 16th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly News Roundup – Week of November 3, 2025
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
4
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
5
